Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 243 clinical trials in Breda, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis
The NetherlandsStudy Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
The NetherlandsStudy of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases
The NetherlandsStudy Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression
The NetherlandsStudy of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors
The NetherlandsStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
AustriaStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
The NetherlandsStudy Comparing Infliximab Alone or with Immunosuppressive Drugs for Moderate to Severe Crohn's Disease Patients
The NetherlandsStudy on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)
The NetherlandsStudy on the Effects and Safety of Camizestrant (AZD9833) Compared to Fulvestrant in Postmenopausal Women with Advanced ER-Positive HER2-Negative Breast Cancer
BelgiumStudy on Imlifidase for Treating Acute Inflammation in Patients with Neuromyelitis Optica Spectrum Disorder
The NetherlandsStudy of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, breast cancer, and leukemia treatments. Studies evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Investigations include combination therapies and treatment discontinuation strategies for various cancer types.
Research focusing on coronary artery disease and post-procedural care, including innovative diagnostic techniques and antithrombotic strategies.
Emphasis on personalized treatment approaches and diagnostic accuracy improvement.
Clinical trials examining respiratory infections and chronic conditions, including vaccine development and asthma management strategies.
Focus on both preventive measures and treatment optimizations for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
